, medical therapy is preferred. The severity of
stenosis may not be the best predictor of plaque behavior,
but it is reproducibly quantifiable and currently used as the
measure of disease severity in all clinical trials. We recognize
that in the future these guidelines will be revised if new
methodologies can better predict the clinical behavior of
atherosclerotic plaques.
Consensus eluded the authors in several areas. We could
not completely agree on the role of carot